Edition:
India

Alkem Laboratories Ltd (ALKE.NS)

ALKE.NS on National Stock Exchange of India

1,952.50INR
21 Jun 2018
Change (% chg)

Rs-6.50 (-0.33%)
Prev Close
Rs1,959.00
Open
Rs1,968.80
Day's High
Rs1,976.15
Day's Low
Rs1,945.05
Volume
9,075
Avg. Vol
35,542
52-wk High
Rs2,469.00
52-wk Low
Rs1,578.30

Latest Key Developments (Source: Significant Developments)

India's Alkem Labs March-Qtr Consol Profit More Than Halves
Wednesday, 30 May 2018 

May 30 (Reuters) - Alkem Laboratories Ltd ::MARCH QUARTER CONSOL PROFIT 670.8 MILLION RUPEES VERSUS PROFIT 1.37 BILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 15.13 BLNRUPEES VERSUS 12.51 BILLION RUPEES YEAR AGO.RECOMMENDED DIVIDEND OF 7 RUPEES PER SHARE.  Full Article

Alkem Laboratories Gets Form 483 With 13 Observations After U.S. FDA Inspection At Co's Amaliya Facility​
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Alkem Laboratories Ltd ::GOT A FORM 483 WITH 13 OBSERVATIONS AFTER US FDA INSPECTION AT CO'S MANUFACTURING FACILITY AT AMALIYA, DAMAN​.SAYS ‍ US FDA HAD CONDUCTED INSPECTION AT THE FACILITY FROM MARCH 19-27.SHALL PUT TOGETHER DETAILED RESPONSE WITH ADEQUATE CORRECTIVE AND PREVENTIVE MEASURES TO ADDRESS US FDA OBSERVATIONS​.‍IN RESPONSE TO FORM 483 BY FDA AT CO'S ST LOUIS FACILITY, CO HAS SUBMITTED CORRECTIVE AND PREVENTIVE ACTION PLAN ​.  Full Article

Alkem Laboratories Announces Closure of U.S.FDA Inspection at Baddi Manufacturing Facility
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Alkem Laboratories Ltd ::SAYS U.S. FDA ISSUES EIR FOR CO'S MANUFACTURING FACILITY AT BADDI.SAYS ‍INSPECTION OF CO'S MANUFACTURING FACILITY AT BADDI HAS NOW BEEN CLOSED BY US FDA​.IN RESPONSE TO TWO FORM 483 OBSERVATIONS ISSUED BY FDA, CO SUBMITTED DETAILED CORRECTIVE AND PREVENTIVE ACTION PLAN TO REGULATOR.  Full Article

India's Alkem Laboratories Gets Shareholders' Nod For Appointment Of Sandeep Singh As MD
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Alkem Laboratories Ltd ::GETS SHAREHOLDERS' NOD FOR APPOINTMENT OF SANDEEP SINGH AS MD.GETS SHAREHOLDERS' NOD FOR RE-APPOINTMENT OF DHANANJAY KUMAR SINGH AS JOINT MD.  Full Article

India's Alkem Labs Sept-qtr consol profit rises
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Alkem Laboratories Ltd ::Sept quarter consol profit 3.27 billion rupees versus 2.88 billion rupees year ago.Sept quarter consol revenue from operations 18.65 billion rupees versus 16.38 billion rupees year ago.  Full Article

India's Alkem Laboratories CEO Prabhat Agrawal resigns
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Alkem Laboratories Ltd :Says Prabhat Agrawal resigns as CEO.  Full Article

Alkem laboratories gets inspection report from US FDA with two 483 observations
Monday, 18 Sep 2017 

Sept 18 (Reuters) - Alkem Laboratories Ltd :Says has received inspection report which contains two 483 observations.Alkem Laboratories- US FDA inspection at facility located at Baddi from 11th September to 15th September.  Full Article

Alkem Labs says US FDA issues EIR for Baddi manufacturing facility
Tuesday, 23 May 2017 

May 23 (Reuters) - Alkem Laboratories Ltd :Says US FDA has issued an establishment inspection report for its Baddi manufacturing facility.Says inspection has now been closed by the USFDA.  Full Article

Alkem Labs says US FDA finds critical observations for co's Daman unit
Thursday, 29 Sep 2016 

Alkem Laboratories Ltd: Update on US FDA inspection at Alkem’s Daman facility . Co has received inspection report which contains thirteen 483 observations .Co shall put together detailed response with adequate corrective and preventive measures to address US FDA observations.  Full Article

Alkem Labs June-qtr profit rises
Friday, 12 Aug 2016 

Alkem Laboratories Ltd : June-quarter net profit 2.51 billion rupees versus 1.72 billion rupees last year . June-quarter net sales 11.42 billion rupees versus 9.38 billion rupees last year .  Full Article

India's Alkem Labs gets USFDA report about Amaliya unit

India's Alkem Labs Ltd said on Wednesday the United States Food and Drug Administration (USFDA) has issued a report about its Amaliya facility, citing 13 observations following an inspection.